William D. Humphries
Mr. Humphries has served as a director of Clearside since 2012 and as the Chair of our Board of Directors from 2018 to June 2023. He currently serves as the Chief Executive Officer of Alcami Corporation, a contract development and manufacturing organization. Prior to Alcami, Humphries' executive leadership roles included CEO at Isosceles Pharmaceuticals, President and Group Company Chairman of Ortho-Dermatologics, CEO of Merz North America, President of Stiefel, a GSK Company, and Vice President of US Skincare at Allergan Pharmaceuticals. Mr. Humphries is an experienced leader in the life sciences industry, serving as Executive Chairman of Strata Skin Sciences, and as a member of the Board of Directors at Alcami Corporation, Aclaris Therapeutics, PhaseBio Pharmaceuticals, SKNV, and Bryn Pharmaceuticals. Mr. Humphries received his M.B.A. degree from Pepperdine University and a B.A. degree from Bucknell University.